DRKS00011646已完成不适用
Are there abnormalities in hemostasis in patients with duchenne muscular dystrophy? - DMD-Coagulation
niversitätsklinikum Freiburg- Zentrum für Kinder- und JugendmedizinKlinik für Neuropädiatrie und Muskelerkrankungen0 个研究点目标入组 53 人开始时间: 2017年2月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 53
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6 Years 至 one(—)
- 性别
- Male
入选标准
- •RETROSPECTIVE PART
- •-registration in the DMD patient registry of the TREAT-NMD-network
- •PROSPECTIVE PART
- •-male patients, aged 6 and above
- •-assured DMD diagnosis, confirmed by genetic results or muscle biopsy
- •-written approval of the person having the custody of the child
- •-written approval of the patient as far as he is by age and stage of development able to understand the character, significance and bearing of the research project and is able to declare hereafter his intention
- •-sufficient ability for cooperation in echocardiographic examination (during routine examination)
排除标准
- •RETROSPECTIVE PART:
- •PROSPECTIVE PART:
- •-overweight with Body Mass Index > 30 body weight/m²
- •-anamnesis or any hint of an intracranial and/or malignant tumor
- •-known or persistent medical drug abuse, illegal drug abuse or alcohol abuse
研究者
相似试验
尚未招募
不适用
Abnormalities in Blood in people living with HIVCTRI/2020/01/022632Maulana Azad Medical College
尚未招募
不适用
Hematological and biochemical abnormalities parameters in the severity of COVID-19CTRI/2020/10/028523Parumkhswami Medicall College and Shree Krishna Hospital200
招募中
不适用
Predictors of Bleeding Evaluation in Adult Hematologic Patients with Bleeding Tendencies. Patients with established bleeding disorders: The BePa verification studyvon Willebrand disease, platelet function disorders, coagulation factor deficiencies, fibrinolysis disorders, bleeding of unknown causeNL-OMON29235MUMC+150
进行中(未招募)
1 期
Does the underlying haemodynamic abnormality determine response to antihypertensive therapy in patients with hypertension? - Does the underlying haemodynamic abnormality determine response to antihypertensive therapy?Essential hypertensionMedDRA version: 9.1 Level: LLT Classification code 10004254 Term: Benign essential hypertensionEUCTR2006-006981-40-GBCambridge University Hospitals NHS Foundation Trust jointly with University of Cambridge60
已完成
不适用
Does the underlying haemodynamic abnormality determine response to antihypertensive therapy?Topic: CardiovascularSubtopic: Cardiovascular (all Subtopics)Disease: CardiovascularCirculatory SystemHypertensionISRCTN56916002Cambridge University Hospitals NHS Foundation Trust (UK)60
